165 related articles for article (PubMed ID: 20117932)
1. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
Wöckel A; Kurzeder C; Geyer V; Novasphenny I; Wolters R; Wischnewsky M; Kreienberg R; Varga D
Breast; 2010 Apr; 19(2):120-7. PubMed ID: 20117932
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
3. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.
Wöckel A; Varga D; Atassi Z; Kurzeder C; Wolters R; Wischnewsky M; Wulff C; Kreienberg R
Onkologie; 2010; 33(1-2):21-8. PubMed ID: 20164658
[TBL] [Abstract][Full Text] [Related]
4. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
6. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
Varga D; Wischnewsky M; Atassi Z; Wolters R; Geyer V; Strunz K; Kreienberg R; Woeckel A
Oncology; 2010; 78(3-4):189-95. PubMed ID: 20414007
[TBL] [Abstract][Full Text] [Related]
7. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
Schwentner L; Van Ewijk R; Kurzeder C; Hoffmann I; König J; Kreienberg R; Blettner M; Wöckel A
Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis.
van de Water W; Bastiaannet E; Dekkers OM; de Craen AJ; Westendorp RG; Voogd AC; van de Velde CJ; Liefers GJ
Br J Surg; 2012 Jun; 99(6):813-20. PubMed ID: 22492310
[TBL] [Abstract][Full Text] [Related]
10. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
11. Adherence to quality indicators and survival in patients with breast cancer.
Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
[TBL] [Abstract][Full Text] [Related]
12. Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands.
Weggelaar I; Aben KK; Warlé MC; Strobbe LJ; van Spronsen DJ
Breast J; 2011; 17(3):239-45. PubMed ID: 21477166
[TBL] [Abstract][Full Text] [Related]
13. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
16. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
17. Does adherence to the guideline recommendation for active treatments improve the quality of care for patients with acute low back pain delivered by physical therapists?
Fritz JM; Cleland JA; Brennan GP
Med Care; 2007 Oct; 45(10):973-80. PubMed ID: 17890995
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer treatment among women of different ethnicity in Hawaii.
Issell BF; Maskarinec G; Pagano I; Gotay CC
Cancer Invest; 2005; 23(6):497-504. PubMed ID: 16203657
[TBL] [Abstract][Full Text] [Related]
19. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
20. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]